Loading...
27 Malaysia Pharmaceuticals Reports
Country Covered: Malaysia
Study Period: 2019 - 2029
Major Players: Eli Lilly, Boehringer Ingelheim, Astrazeneca, Sanofi, NovoNordisk
Country Covered: Malaysia
Study Period: 2019 - 2029
Major Players: Astrazeneca, Astellas, Janssen, Eli Lilly, Sanofi
Country Covered: Malaysia
Study Period: 2018 - 2029
Major Players: Astrazeneca, Boehringer Ingelheim, Novo Nordisk A/S, Eli Lilly and Company, Sanofi Aventis
Country Covered: Malaysia
Study Period: 2018 - 2029
Major Players: AstraZeneca, Eli Lilly and Company, Merck and Co., Novartis AG, Bristol-Myers Squibb
Country Covered: Malaysia
Study Period: 2018 - 2029
Major Players: Takeda, Pfizer, Bayer, Sun Pharma, Glenmark
Country Covered: Malaysia
Study Period: 2018 - 2029
Major Players: Eli Lilly, Boehringer Ingelheim, Janssen Pharmaceuticals, AstraZeneca, Bristol Myers Squibb
Country Covered: Malaysia
Study Period: 2019 - 2029
Major Players: Takeda, Bristol-Myers Squibb, Glenmark, Merck and Co., Sanofi Aventis
Country Covered: Malaysia
Study Period: 2018 - 2029
Major Players: AstraZeneca, Eli Lilly and Company, Novo Nordisk A/S, Sanofi Aventis, Biocon Ltd.
Country Covered: Malaysia
Study Period: 2019 - 2029
Major Players: Novo Nordisk, Eli Lilly, Sanofi, Biocon, Gan & Lee
Country Covered: Malaysia
Study Period: 2018 - 2029
Major Players: Novo Nordisk, Glenmark, Novartis, Kissei, Biocon
Country Covered: Malaysia
Study Period: 2018 - 2029
Major Players: Sun Pharma, Bayer, Takeda, Torrent Pharmaceuticals, Pfizer Inc.
Country Covered: Malaysia
Study Period: 2019- 2029
Major Players: Glenmark Pharmaceuticals, Novartis, Kissei Pharmaceuticals, Biocon, Novo Nordisk A/S
Country Covered: Malaysia
Study Period: 2019 - 2029
Major Players: Janssen Pharmaceuticals, Eli Lilly, Bristol Myers Squibb, AstraZeneca Pharmaceuticals, Astellas
Country Covered: Malaysia
Study Period: 2018 - 2029
Major Players: Merck, AstraZeneca, Boehringer Ingelheim Pharmaceuticals Inc., Pfizer Inc., Eli Lilly and Company
Country Covered: Malaysia
Study Period: 2018-2029
Major Players: Novo Nordisk A/S
Country Covered: Malaysia
Study Period: 2019- 2029
Major Players: Boehringer Ingelheim, Sanofi Aventis, Merck & Co., Inc., Eli Lilly and Company, Novo Nordisk A/S
Country Covered: Malaysia
Study Period: 2018 - 2029
Major Players: Sanofi Aventis, Novo Nordisk AS, Biocon, Eli Lilly and Company, Julphar
Country Covered: Malaysia
Study Period: 2019 - 2029
Major Players: Novo Nordisk, Sanofi, Eli Lilly, Biocon, Wockhardt
Country Covered: Malaysia
Study Period: 2018-2029
Major Players: Novo Nordisk, Lilly, Julphar, Biocon, Sanofi
Country Covered: Malaysia
Study Period: 2019 - 2029
Major Players: Novo Nordisk, Sanofi, AstraZeneca, Boehringer Ingelheim, Eli Lilly and Company
Country Covered: Malaysia
Study Period: 2019- 2029
Major Players: AstraZeneca, Eli Lilly and Company, Sanofi, Novo Nordisk A/S, Pfizer Inc.
Country Covered: Malaysia
Study Period: 2019- 2029
Major Players: Sanofi Aventis, Pfizer Inc., Merck & Co., Inc., Torrent Pharma, Dr. Reddy's Laboratories
Country Covered: Malaysia
Study Period: 2018 - 2029
Major Players: Eli Lilly and Company, Astellas Pharma Inc., Sanofi S.A., Janssen Pharmaceuticals, AstraZeneca
Country Covered: Malaysia
Study Period: 2018 - 2029
Major Players: Bristol Myers Squibb, Glenmark Pharmaceuticals, Takeda, Sanofi Aventis, Merck and Co.